CRE Recombinase (CRE) (AA 287-314), (C-Term) Antikörper
Kurzübersicht für CRE Recombinase (CRE) (AA 287-314), (C-Term) Antikörper (ABIN2793617)
Target
Alle CRE Recombinase (CRE) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 287-314, C-Term
-
Verwendungszweck
- Rabbit Anti-Human CREM (C-term) Antibody
-
Immunogen
- This CREM antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 287-314 amino acids from the C-terminal region of human CREM.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
Western Blot, Flow Cytometry
Recommended Dilutions
WB: 1:1000, FC: 1:10-50Western blot analysis of CREM Antibody (C-term) .FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 2.0 mg/mL
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2-8°C (short-term), -20°C (long-term)
-
-
- CRE Recombinase (CRE)
-
Andere Bezeichnung
- CRE
-
Substanzklasse
- Phage Protein
-
Hintergrund
-
Target Description: CREM is a bZIP transcription factor that binds to the cAMP responsive element found in many viral and cellular promoters. It is an important component of cAMP-mediated signal transduction during the spermatogenetic cycle, as well as other complex processes.
Gene Symbol: CREM
-
Molekulargewicht
- 38940 Da
-
Gen-ID
- 1390
-
UniProt
- Q03060
Target
-